Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)
Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)
Recruiting · NCT06159478 · Registry updated 2023-12-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, low grade glioma, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Phase 2 | 2023-12-13 | NCT06159478 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Center, Japan | 16 |
| Ono Pharmaceutical Co., Ltd. | 47 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hokkaido University Hospital | Sapporo | Japan | 59 |
| Kyoto University Hospital | Kyoto | Japan | 7 |
| Kyushu University Hospital | Fukuoka | Japan | 53 |
| National Cancer Center Hospital East | Kashiwa | Japan | 67 |
| National Cancer Center Japan | Chuo-ku | Japan | 1 |
| Tohoku University Hospital | Sendai | Japan | 55 |